FARALLON CAPITAL MANAGEMENT LLC Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$15.4B
Holdings
131
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (131 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | IQVIQVIA HLDGS INC | 4,043,506 | $724.5B | 4713.58% | |
| 2 | GOOGALPHABET INC | 361,094 | $632.6B | 4115.78% | |
| 3 | TMUST-MOBILE US INC | 3,949,181 | $532.5B | 3464.86% | |
| 4 | TMOTHERMO FISHER SCIENTIFIC INC | 1,114,248 | $519.0B | 3376.68% | |
| 5 | SPYSPDR S&P 500 ETF TR | 1,365,000 | $510.3B | 3320.42% | Put |
| 6 | VVISA INC | 2,228,104 | $487.4B | 3170.82% | |
| 7 | AONAON PLC | 2,271,514 | $479.9B | 3122.35% | |
| 8 | BSXBOSTON SCIENTIFIC CORP | 13,238,319 | $475.9B | 3096.42% | |
| 9 | FISFIDELITY NATL INFORMATION SV | 3,149,118 | $445.5B | 2898.35% | |
| 10 | ARMKARAMARK | 11,023,949 | $424.2B | 2759.95% | |
| 11 | CNCCENTENE CORP DEL | 6,850,000 | $411.2B | 2675.39% | |
| 12 | ELVANTHEM INC | 1,275,000 | $409.4B | 2663.58% | |
| 13 | MSFTMICROSOFT CORP | 1,758,168 | $391.1B | 2544.27% | |
| 14 | WABWABTEC | 4,997,371 | $365.8B | 2380.02% | |
| 15 | CHTRCHARTER COMMUNICATIONS INC N | 546,931 | $361.8B | 2354.09% | |
| 16 | NYTNEW YORK TIMES CO | 6,545,329 | $338.9B | 2204.64% | |
| 17 | XLRNACCELERON PHARMA INC | 2,600,000 | $332.6B | 2164.25% | |
| 18 | RTXRAYTHEON TECHNOLOGIES CORP | 4,542,306 | $324.8B | 2113.35% | |
| 19 | METAFACEBOOK INC | 1,154,005 | $315.2B | 2050.94% | |
| 20 | CRMSALESFORCE COM INC | 1,409,045 | $313.6B | 2040.05% | |
| 21 | TIFEURTIFFANY & CO NEW | 2,287,000 | $300.6B | 1955.94% | |
| 22 | SHWSHERWIN WILLIAMS CO | 389,366 | $286.1B | 1861.74% | |
| 23 | IOVAIOVANCE BIOTHERAPEUTICS INC | 6,000,000 | $278.4B | 1811.33% | |
| 24 | FATEFATE THERAPEUTICS INC | 3,000,000 | $272.8B | 1774.83% | |
| 25 | AVGOBROADCOM INC | 622,995 | $272.8B | 1774.75% | |
| 26 | BXBLACKSTONE GROUP INC | 3,891,886 | $252.2B | 1641.08% | |
| 27 | EX9EXELIXIS INC | 11,000,000 | $220.8B | 1436.38% | |
| 28 | EDUNEW ORIENTAL ED & TECHNOLOGY | 1,154,300 | $214.5B | 1395.45% | |
| 29 | WTWWILLIS TOWERS WATSON PLC LTD | 962,500 | $202.8B | 1319.33% | |
| 30 | BABAALIBABA GROUP HLDG LTD | 853,300 | $198.6B | 1292.06% | |
| 31 | MRTXEURMIRATI THERAPEUTICS INC | 875,000 | $192.2B | 1250.40% | |
| 32 | HLTHILTON WORLDWIDE HLDGS INC | 1,640,437 | $182.5B | 1187.48% | |
| 33 | —QIAGEN NV | 3,256,771 | $172.1B | 1119.85% | |
| 34 | TRUTRANSUNION | 1,734,082 | $172.1B | 1119.43% | |
| 35 | ASNDASCENDIS PHARMA A/S | 1,000,000 | $166.8B | 1085.11% | |
| 36 | HWMHOWMET AEROSPACE INC | 4,891,479 | $139.6B | 908.29% | |
| 37 | APLSAPELLIS PHARMACEUTICALS INC | 2,275,000 | $130.1B | 846.65% | |
| 38 | ABBVABBVIE INC | 1,150,000 | $123.2B | 801.71% | |
| 39 | AMRSEURAMYRIS INC | 17,500,000 | $108.1B | 703.08% | |
| 40 | SRPTSAREPTA THERAPEUTICS INC | 600,000 | $102.3B | 665.55% | |
| 41 | MOMO 1.25 07/01/25MOMO INC | 110,077,000 | $93.5B | 608.06% | |
| 42 | PCGPG&E CORP | 7,292,042 | $90.9B | 591.15% | |
| 43 | SG7SAGE THERAPEUTICS INC | 1,050,000 | $90.8B | 591.00% | |
| 44 | PLYAPLAYA HOTELS & RESORTS NV | 14,994,867 | $89.2B | 580.48% | |
| 45 | LULUFAX HOLDING LTD | 5,357,750 | $76.1B | 494.99% | |
| 46 | ENTAENANTA PHARMACEUTICALS INC | 1,775,000 | $74.7B | 486.20% | |
| 47 | —BROADMARK RLTY CAP INC | 7,170,213 | $73.1B | 475.84% | |
| 48 | KSUEURKANSAS CITY SOUTHERN | 354,400 | $72.3B | 470.69% | |
| 49 | IQ 2 04/01/25IQIYI INC | 81,762,000 | $71.8B | 466.89% | |
| 50 | EFXEQUIFAX INC | 370,684 | $71.5B | 465.08% | |
| 51 | KRTXKARUNA THERAPEUTICS INC | 700,000 | $71.1B | 462.68% | |
| 52 | FGENEURFIBROGEN INC | 1,900,000 | $70.5B | 458.50% | |
| 53 | BCABBIOATLA INC | 1,967,060 | $66.9B | 435.27% | |
| 54 | GBIOGBXGENERATION BIO CO | 2,268,819 | $64.3B | 418.49% | |
| 55 | ARNAEURARENA PHARMACEUTICALS INC | 750,000 | $57.6B | 374.91% | |
| 56 | PACBPACIFIC BIOSCIENCES CALIF IN | 2,100,000 | $54.5B | 354.42% | |
| 57 | —THERAVANCE BIOPHARMA INC | 56,695,000 | $53.8B | 350.07% | |
| 58 | CYTKCYTOKINETICS INC | 2,400,000 | $49.9B | 324.48% | |
| 59 | PTGXPROTAGONIST THERAPEUTICS INC | 2,425,000 | $48.9B | 318.08% | |
| 60 | ALNYALNYLAM PHARMACEUTICALS INC | 350,000 | $45.5B | 295.97% | |
| 61 | —ZOGENIX INC | 2,250,000 | $45.0B | 292.64% | |
| 62 | CLGXCORELOGIC INC | 574,028 | $44.4B | 288.77% | |
| 63 | KPTI 3 10/15/25KARYOPHARM THERAPEUTICS INC | 35,000,000 | $43.5B | 283.20% | |
| 64 | AGIOAGIOS PHARMACEUTICALS INC | 1,000,000 | $43.3B | 281.91% | |
| 65 | ISIIONIS PHARMACEUTICALS INC | 750,000 | $42.4B | 275.90% | |
| 66 | ANNXANNEXON INC | 1,557,261 | $39.0B | 253.60% | |
| 67 | —RADIUS HEALTH INC | 2,107,400 | $37.6B | 244.88% | |
| 68 | CARAEURCARA THERAPEUTICS INC | 2,465,000 | $37.3B | 242.65% | |
| 69 | INSM 1.75 01/15/25INSMED INC | 32,500,000 | $36.6B | 237.81% | |
| 70 | CLVS 1.25 05/01/25CLOVIS ONCOLOGY INC | 51,910,000 | $36.1B | 234.72% | |
| 71 | LNTHLANTHEUS HLDGS INC | 2,650,000 | $35.7B | 232.59% | |
| 72 | —ZYMEWORKS INC | 750,000 | $35.4B | 230.61% | |
| 73 | KRYSKRYSTAL BIOTECH INC | 525,000 | $31.5B | 204.95% | |
| 74 | NVV1NOVAVAX INC | 275,000 | $30.7B | 199.51% | |
| 75 | —IQIYI INC | 29,689,000 | $29.9B | 194.50% | |
| 76 | —PANACEA ACQUISITION CORP | 2,500,000 | $29.3B | 190.31% | |
| 77 | AM6AMICUS THERAPEUTICS INC | 1,250,000 | $28.9B | 187.79% | |
| 78 | —CLEVER LEAVES HOLDINGS INC | 2,478,079 | $28.7B | 186.92% | |
| 79 | DMTKQDERMTECH INC | 861,090 | $27.9B | 181.74% | |
| 80 | BIIBBIOGEN INC | 103,000 | $25.2B | 164.09% | |
| 81 | —CONSTELLATION PHARMCETICLS I | 750,000 | $21.6B | 140.53% | |
| 82 | BEKEKE HLDGS INC | 343,000 | $21.1B | 137.33% | |
| 83 | GRFSGRIFOLS S A | 1,115,000 | $20.6B | 133.77% | |
| 84 | IQ 4 12/15/26IQIYI INC | 20,000,000 | $20.0B | 130.12% | |
| 85 | —ZEALAND PHARMA A/S | 510,000 | $18.3B | 119.25% | |
| 86 | —ATENTO S A | 2,230,357 | $18.2B | 118.59% | |
| 87 | PLRXPLIANT THERAPEUTICS INC | 764,262 | $17.4B | 112.97% | |
| 88 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 300,000 | $17.1B | 111.39% | |
| 89 | INBXUSDINHIBRX INC | 510,000 | $16.8B | 109.40% | |
| 90 | RCREADY CAPITAL CORP | 1,350,226 | $16.8B | 109.37% | |
| 91 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 1,500,000 | $16.3B | 105.79% | |
| 92 | BMYBRISTOL-MYERS SQUIBB CO | 250,000 | $15.5B | 100.90% | |
| 93 | BMY-RBRISTOL-MYERS SQUIBB CO | 21,400,000 | $14.8B | 96.08% | |
| 94 | PRAXPRAXIS PRECISION MEDICINES I | 250,000 | $13.8B | 89.49% | |
| 95 | XPOXPO LOGISTICS INC | 110,000 | $13.1B | 85.31% | |
| 96 | —NUANCE COMMUNICATIONS INC | 7,000,000 | $13.1B | 84.92% | |
| 97 | NTLAINTELLIA THERAPEUTICS INC | 225,000 | $12.2B | 79.64% | |
| 98 | —TIGA ACQUISITION CORP | 1,080,000 | $11.4B | 74.34% | |
| 99 | —AVROBIO INC | 795,000 | $11.1B | 72.10% | |
| 100 | RCKTROCKET PHARMACEUTICALS INC | 200,000 | $11.0B | 71.36% |
Page 1 of 2Next